Market Value141,301,000
Total Holdings60
File Date2022-11-07
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
INBX / Inhibrx Biosciences, Inc.
ANGN / Angion Biomedica Corp
XENE / Xenon Pharmaceuticals Inc.
TPTX / Turning Point Therapeutics Inc
CCXI / ChemoCentryx Inc
KNSA / Kiniksa Pharmaceuticals, Ltd.
CNCE / Concert Pharmaceuticals Inc
NARI / Inari Medical, Inc.
LSF / Laird Superfood, Inc.
CFRX / ContraFect Corp
QDEL / QuidelOrtho Corporation
IMGN / ImmunoGen, Inc.
IRTC / iRhythm Technologies, Inc.
NKTR / Nektar Therapeutics
SIEN / Sientra, Inc.
CLR / Continental Resources Inc (OKLA)
AVEO / AVEO Pharmaceuticals Inc
ISEE / IVERIC bio Inc
SLNO / Soleno Therapeutics, Inc.
ALBO / Albireo Pharma Inc
YTEN / Yield10 Bioscience, Inc.
ETRN / Equitrans Midstream Corporation
PXD / Pioneer Natural Resources Company
GTHX / G1 Therapeutics, Inc.
SILK / Silk Road Medical, Inc
KALV / KalVista Pharmaceuticals, Inc.
OVV / Ovintiv Inc.
HROW / Harrow, Inc.
MASI / Masimo Corporation
/ VENTYX BIOSCIENCES INC
ATEC / Alphatec Holdings, Inc.
APLS / Apellis Pharmaceuticals, Inc.
TSVT / 2seventy bio, Inc.
NBIX / Neurocrine Biosciences, Inc.
CGEM / Cullinan Therapeutics, Inc.
IFRX / InflaRx N.V.
AZYO / Aziyo Biologics Inc - Class A
DCGO / DocGo Inc.
BHVN / Biohaven Ltd.
PTGX / Protagonist Therapeutics, Inc.
SRPT / Sarepta Therapeutics, Inc.
ALKS / Alkermes plc
BMY / Bristol-Myers Squibb Company
AXDX / Accelerate Diagnostics, Inc.
AWH / Aspira Women's Health Inc.
UTHR / United Therapeutics Corporation
BCRX / BioCryst Pharmaceuticals, Inc.
FOLD / Amicus Therapeutics, Inc.
STOK / Stoke Therapeutics, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
CYTK / Cytokinetics, Incorporated
CORT / Corcept Therapeutics Incorporated
ZNTL / Zentalis Pharmaceuticals, Inc.
BDSX / Biodesix, Inc.
GOSS / Gossamer Bio, Inc.
XNCR / Xencor, Inc.
ARVN / Arvinas, Inc.
BLUE / bluebird bio, Inc.
PHR / Phreesia, Inc.
FHTX / Foghorn Therapeutics Inc.
PRTA / Prothena Corporation plc
KPTI / Karyopharm Therapeutics Inc.